Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna

Patent No. EP2750707 (titled "Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna") was filed by GlaxoSmithKline Biologicals SA on Aug 31, 2012. The application was issued on Oct 24, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANJul 24, 2019MEWBURN ELLIS
MÜLLER, DIERKJul 23, 2019-
MÜLLER, CHRISTIANJul 23, 2019-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2750707

GLAXOSMITHKLINE BIOLOGICALS SA
Application Number
EP12769787A
Filing Date
Aug 31, 2012
Status
Revoked
Oct 25, 2023
Publication Date
Oct 24, 2018